Utrogestan Vaginal 200 mg Capsules
What this means
The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.
Class 2 recall · DMRC-35159465
| Product | Licence | Active ingredient | GTIN |
|---|---|---|---|
| Utrogestan Vaginal 200 mg Capsules | progesterone | 5056318902210 |
Batches (expiry): 234376/A (30/09/2026), 241347/A (30/04/2026), 234376/B (30/09/2026), 241347/B (30/04/2026), 241347/C (30/04/2026), 241347/D (30/04/2026)
Background: Uni Health Distribution Ltd has informed the MHRA of a typographical error on the approved carton overlabel for Utrogestan Vaginal 200 mg Capsules. The carton label references ‘micrograms’ where it should actually state ‘milligrams’. Advice for Healthcare Professionals: Stop supplying the affected batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.